SL Science Holding SLBT
NASDAQ SLBT
$1.17 -0.04 (-3.31%)
At close: Oct 29, 2026 · 4:00 PM EDT

SL Science Holding (SLBT) Preferred Stock Liabilities (2026)

Updated

SL Science Holding's Preferred Stock Liabilities came in at $37.48 million for Q1 2026.

Analysis

SL Science Holding (SLBT) Preferred Stock Liabilities (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn -
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn -
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn -
4 Merck 370.60 Bn 370.60 Bn - -
5 Novartis Ag 311.97 Bn 285.20 Bn - -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn -
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn -
8 Gilead Sciences 213.47 Bn 213.47 Bn - -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn -
10 SL Science Holding 2.82 Bn 2.80 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 37.48 Mn
API Access

SL Science Holding Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SLBT&period=max&api_key=YOUR_API_KEY